Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.

Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast Cancer Res Treat. 2012 Apr; 132(3):1063-72.

View in: PubMed

subject areas

Acetylation
Adult
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Biomarkers, Tumor
Breast Neoplasms
Disease-Free Survival
Female
HSP90 Heat-Shock Proteins
Humans
Hydroxamic Acids
Kaplan-Meier Estimate
Liver Neoplasms
Lung Neoplasms
Middle Aged
Paclitaxel
Protein Processing, Post-Translational
Treatment Outcome
Tubulin

authors with profiles

WARREN C FISKUS
KAPIL BHALLA